ISPO

Molecular Genetics & Therapy - 2

Genetic polymorphisms

F. F. Kadlubar, Ph.D.

Pharmacogenomics in cancer drug discovery and development

P Workman

Therapeutic windows in the genetic engineering of hematopoietic cells

Christopher Baum1,2, Zhixiong Li1,2, Bernd Schiedlmeier2, Hannes Klump2, Elke Will2, Jochen Düllmann3, Johann Meyer1, Martin Forster2, Carol Stocking2, Wolfram Ostertag2, Manfred Schmidt4, Christof von Kalle4, Axel R. Zander5, Boris Fehse5

Mutations of TP53 in cancers of the head and neck and of the oesophagus: implications for the identification of environmental factors of risk.

Pierre Hainaut, PhD